AKT1 and neoplasm: Beyond its potent antiangiogenic effects, Apatinib has been shown to modulate tumor-associated signaling pathways such as PI3K/AKT/mTOR and ROS/Nrf2/p62, thereby promoting tumor cell apoptosis and enhancing sensitivity to chemotherapeutic agents [27,28].